## Core Concept
The management of tuberculosis (TB) in pregnancy requires careful consideration of both the mother's health and the potential risks to the fetus. The treatment of TB involves a combination of antitubercular drugs to prevent the development of drug resistance.

## Why the Correct Answer is Right
The correct approach for managing sputum-positive TB in a pregnant woman at 6 weeks gestation involves initiating antitubercular therapy while closely monitoring for potential side effects and ensuring the well-being of both the mother and the fetus. The first-line antitubercular drugs recommended during pregnancy are isoniazid (INH), rifampicin (RMP), ethambutol (EMB), and pyrazinamide (PZA). However, the use of these drugs, especially during the first trimester, requires careful consideration due to potential teratogenic effects. Despite these concerns, the benefits of treating TB usually outweigh the risks, and the regimen is often started with INH, RMP, EMB, and PZA for the initial 2 months, followed by INH and RMP for 4 months.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is not provided, but typically, incorrect options might suggest delaying treatment until after pregnancy or using less effective or unproven regimens.
- **Option B:** Similarly, without specifics, an incorrect option might propose using drugs contraindicated in pregnancy or omitting essential components of TB treatment.
- **Option D:** Another incorrect option could suggest a different management strategy that does not align with current guidelines for TB treatment in pregnancy.

## Clinical Pearl / High-Yield Fact
A key point to remember is that TB treatment should not be delayed in pregnancy due to the risks to both the mother and the fetus. Isoniazid prophylaxis is recommended for pregnant women with latent TB infection. Pyridoxine (vitamin B6) supplementation is often recommended alongside isoniazid to prevent peripheral neuropathy.

**Correct Answer:** .